◆ KD PIPELINE summary
Information as of 2025.11
| Category | assignment | Therapeutic Area / Target | Progress stage | |||||
|---|---|---|---|---|---|---|---|---|
| Discovery | Non-clinical | Phase 1 clinical trial | Phase 2 clinical trial | Phase 3 clinical trial | permission | |||
| Innovative new drug | KD2410 | immunotherapy | Complete | |||||
| Biologics | KDB2401 | Skin (atopy) | Complete | |||||
| KDB2501 | Skin (atopy) | Complete | ||||||
| Incrementally Modified Drugs | KDF1905 | urinary system | Complete | Complete | Complete | |||
| KDF1901 | Antihypertensive Agents | Complete | Complete | Complete | Complete | |||
| KD2408 | obesity | Complete | ||||||
| KD2502 | dyslipidemia | Complete | ||||||
| KD2503 | dry eye syndrome | Complete | ||||||
| KD2406 | digestive system | Complete | ||||||
| KD2504 | diabetes | Complete | ||||||
| KD2505 | diabetes | Complete | ||||||
Innovative new drug
KD2410
immunotherapy
- Discovery
- Complete
- Non-clinical
- —
- Phase 1 clinical trial
- —
- Phase 2 clinical trial
- —
- Phase 3 clinical trial
- —
- permission
- —
Biologics
KDB2401
Skin (atopy)
- Discovery
- Complete
- Non-clinical
- —
- Phase 1 clinical trial
- —
- Phase 2 clinical trial
- —
- Phase 3 clinical trial
- —
- permission
- —
Biologics
KDB2501
Skin (atopy)
- Discovery
- Complete
- Non-clinical
- —
- Phase 1 clinical trial
- —
- Phase 2 clinical trial
- —
- Phase 3 clinical trial
- —
- permission
- —
Incrementally Modified Drugs
KDF1905
urinary system
- Discovery
- Complete
- Non-clinical
- Complete
- Phase 1 clinical trial
- —
- Phase 2 clinical trial
- —
- Phase 3 clinical trial
- Complete
- permission
- —
Incrementally Modified Drugs
KDF1901
Antihypertensive Agents
- Discovery
- Complete
- Non-clinical
- Complete
- Phase 1 clinical trial
- Complete
- Phase 2 clinical trial
- —
- Phase 3 clinical trial
- Complete
- permission
- —
Incrementally Modified Drugs
KD2408
obesity
- Discovery
- Complete
- Non-clinical
- —
- Phase 1 clinical trial
- —
- Phase 2 clinical trial
- —
- Phase 3 clinical trial
- —
- permission
- —
Incrementally Modified Drugs
KD2502
dyslipidemia
- Discovery
- Complete
- Non-clinical
- —
- Phase 1 clinical trial
- —
- Phase 2 clinical trial
- —
- Phase 3 clinical trial
- —
- permission
- —
Incrementally Modified Drugs
KD2503
dry eye syndrome
- Discovery
- Complete
- Non-clinical
- —
- Phase 1 clinical trial
- —
- Phase 2 clinical trial
- —
- Phase 3 clinical trial
- —
- permission
- —
Incrementally Modified Drugs
KD2406
digestive system
- Discovery
- Complete
- Non-clinical
- —
- Phase 1 clinical trial
- —
- Phase 2 clinical trial
- —
- Phase 3 clinical trial
- —
- permission
- —
Incrementally Modified Drugs
KD2504
diabetes
- Discovery
- Complete
- Non-clinical
- —
- Phase 1 clinical trial
- —
- Phase 2 clinical trial
- —
- Phase 3 clinical trial
- —
- permission
- —
Incrementally Modified Drugs
KD2505
diabetes
- Discovery
- Complete
- Non-clinical
- —
- Phase 1 clinical trial
- —
- Phase 2 clinical trial
- —
- Phase 3 clinical trial
- —
- permission
- —
| Category | assignment | Therapeutic Area / Target | Progress stage | |||
|---|---|---|---|---|---|---|
| Discovery | Formulation research | lively | permission | |||
| Generic Medicines | KD2308 | digestive system | Complete | Complete | ||
| KD2303 | dyslipidemia | Complete | Complete | |||
| KD2407 | Antihypertensive Agents | Complete | Complete | |||
| KD2108 | dyslipidemia | Complete | Complete | |||
| KD2409 | GnRH agonist | Complete | Complete | |||
| KD2501 | NSAIDs | Complete | ||||
| KD2102 | digestive system | Complete | Complete | Complete | Complete | |
Generic Medicines
KD2308
digestive system
- Discovery
- Complete
- Formulation research
- Complete
- lively
- —
- permission
- —
Generic Medicines
KD2303
dyslipidemia
- Discovery
- Complete
- Formulation research
- Complete
- lively
- —
- permission
- —
Generic Medicines
KD2407
Antihypertensive Agents
- Discovery
- Complete
- Formulation research
- Complete
- lively
- —
- permission
- —
Generic Medicines
KD2108
dyslipidemia
- Discovery
- Complete
- Formulation research
- Complete
- lively
- —
- permission
- —
Generic Medicines
KD2409
GnRH agonist
- Discovery
- Complete
- Formulation research
- Complete
- lively
- —
- permission
- —
Generic Medicines
KD2501
NSAIDs
- Discovery
- Complete
- Formulation research
- —
- lively
- —
- permission
- —
Generic Medicines
KD2102
digestive system
- Discovery
- Complete
- Formulation research
- Complete
- lively
- Complete
- permission
- Complete
